{
    "medicine_id": "915469c92e6e391ff454932aa3404cd856c8221d",
    "platform_id": "DB09488",
    "metadata": {
        "name": "Semprex D 60 mg Capsule",
        "composition": "60 mg Acrivastine",
        "clinical_particulars": {
            "therapeutic_indications": "For the relief of symptoms associated with seasonal allergic rhinitis such as sneezing rhinorrhea pruritus lacrimation and nasal congestion",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00895",
                        "description": "Acrivastine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Betahistine can be decreased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may decrease the sedative and stimulatory activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Imipramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Acrivastine may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The therapeutic efficacy of Pitolisant can be decreased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Cyclosporine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "Triamterene may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Celecoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "Rofecoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Methotrexate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Carboplatin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Hydrochlorothiazide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "Tepoxalin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "Givosiran may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Lopinavir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Loxoprofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Tositumomab may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Cyanocobalamin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "Fluvoxamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Baclofen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Cevimeline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Lorazepam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Carbidopa may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "Tramadol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "Ticlopidine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Temazepam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Doxycycline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Carmustine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Metoprolol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Topiramate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Acarbose may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Bleomycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Acetaminophen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Floxuridine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "Hydromorphone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "Clobazam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Chlorzoxazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Sulfadiazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Palonosetron may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Dexrazoxane may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Eszopiclone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Alprazolam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Rosiglitazone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Trifluridine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Nitric Oxide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Allopurinol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "Gemcitabine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "Duloxetine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Lenalidomide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Buspirone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Fosinopril may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Flutamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Methoxsalen may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Fondaparinux may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Levocarnitine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Fluocinolone acetonide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Labetalol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Bisoprolol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Clorazepic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Clofarabine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dexmedetomidine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Prednisone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Dyphylline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Verapamil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Chlorpropamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Midazolam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Mycophenolate mofetil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Flurazepam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Phentolamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Tamsulosin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Lisinopril may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Thiabendazole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Nateglinide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tetracycline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Methimazole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Tirofiban may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Propantheline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Perindopril may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Dicyclomine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Pentoxifylline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tadalafil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Diazepam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tolazamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dobutamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Oxazepam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Dacarbazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Temozolomide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Ranitidine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Triazolam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Azacitidine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Isoniazid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Mepivacaine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Methyldopa may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Azathioprine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Auranofin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Levobupivacaine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Ganciclovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Metyrapone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Isosorbide mononitrate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Phylloquinone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Mycophenolic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Topotecan may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Probenecid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Fenofibrate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lubiprostone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Abacavir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Amoxicillin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Glipizide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Dimethyl sulfoxide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Flucytosine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Capecitabine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Sibutramine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Tolbutamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Tiludronic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Doxacurium may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Flavoxate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Nefazodone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Bupropion may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Trimetrexate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Guanethidine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "Ifosfamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Naloxone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Flumazenil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Fomepizole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Estazolam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Budesonide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Epoprostenol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Gemfibrozil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Iodixanol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Sitagliptin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Varenicline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Hydralazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Penbutolol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Colchicine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Tiotropium may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Amrinone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Oxybenzone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Fenproporex may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Bromazepam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Chloral hydrate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Ketazolam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Valganciclovir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Sorbitol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Lorcaserin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Pegaptanib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Milnacipran may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Clevidipine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Migalastat may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Brivaracetam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "Apremilast may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Pentaerythritol tetranitrate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Ipilimumab may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Icatibant may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Alogliptin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Prasugrel may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Doripenem may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Rivaroxaban may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Nalmefene may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Saxagliptin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "Prucalopride may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Flupirtine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Dalfampridine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Dabigatran etexilate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Desvenlafaxine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Fesoterodine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Gadofosveset trisodium may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Methyltestosterone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Ammonium chloride may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Dimercaprol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Mangafodipir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Methylnaltrexone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Plerixafor may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Pralatrexate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Tiopronin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Triethylenetetramine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Ioflupane I 123 may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Deferiprone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "N methylnicotinamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Gabapentin enacarbil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Ruxolitinib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Peginesatide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Aclidinium may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Enzalutamide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Teduglutide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "Certolizumab pegol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Formestane may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Glycerol phenylbutyrate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "Pomalidomide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Trametinib may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "Levomilnacipran may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Macitentan may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Sofosbuvir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Ledipasvir may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Ceftolozane may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Corifollitropin alfa may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Vortioxetine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Tasimelteon may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "Edoxaban may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Idebenone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Tixocortol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Ancestim may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Magnesium hydroxide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Hydroxyethyl Starch may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Pentastarch may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Stiripentol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Aurothioglucose may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Dienogest may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Chromic chloride may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Gadoteric acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Iothalamic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Ioversol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Ioxilan may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Isosulfan blue may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Technetium Tc 99m mebrofenin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Technetium Tc 99m oxidronate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Florbetaben 18F may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Florbetapir 18F may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Iopromide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Technetium Tc 99m exametazime may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Technetium Tc 99m pyrophosphate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Viloxazine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Etoperidone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Lorpiprazole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Arotinolol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Moxisylyte may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Pholcodine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Piracetam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Bisoxatin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Nicorandil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Blonanserin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Dextran may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Tegafur may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Gimeracil may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Imidafenacin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Idarucizumab may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Lixisenatide may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Picosulfuric acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Sodium aurothiomalate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Choline C 11 may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Magnesium trisilicate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Sacubitril may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Chondroitin sulfate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Procaine benzylpenicillin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Sulbactam may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Sodium fluoride may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Antihemophilic Factor Recombinant PEGylated may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Invert sugar may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Dexpanthenol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Phosphoric acid may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Sodium acetate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Magnesium chloride may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Potassium perchlorate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Sodium sulfate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Enalaprilat may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Magnesium carbonate may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Acrivastine may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Acrivastine may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Acrivastine may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Acrivastine may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Acrivastine may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Acrivastine may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Acrivastine may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Acrivastine may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Acrivastine may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Acrivastine may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "Acrivastine may decrease the excretion rate of Opium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Acrivastine may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Acrivastine may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Acrivastine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Acrivastine may decrease the excretion rate of Pyrantel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Acrivastine may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Acrivastine may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Acrivastine may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Acrivastine may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Acrivastine may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Acrivastine may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Acrivastine may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Acrivastine may decrease the excretion rate of Lesinurad which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Acrivastine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Acrivastine may decrease the excretion rate of Etafedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Acrivastine may decrease the excretion rate of Antithrombin III human which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Acrivastine may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Acrivastine may decrease the excretion rate of Tropisetron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Acrivastine may decrease the excretion rate of Baricitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Acrivastine may decrease the excretion rate of Apalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Acrivastine may decrease the excretion rate of Valbenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Acrivastine may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Acrivastine may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Acrivastine may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Acrivastine may decrease the excretion rate of Propiverine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Acrivastine may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Acrivastine may decrease the excretion rate of Tiapride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Acrivastine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Acrivastine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Acrivastine may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Acrivastine may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Acrivastine may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Acrivastine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Acrivastine may decrease the excretion rate of Ipecac which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Acrivastine may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Acrivastine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Acrivastine may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Acrivastine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Acrivastine may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Acrivastine may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Acrivastine may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Acrivastine may decrease the excretion rate of Estradiol acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Acrivastine may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Acrivastine may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Acrivastine may decrease the excretion rate of Estradiol valerate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Acrivastine may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Acrivastine may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Acrivastine may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Acrivastine may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Acrivastine may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Acrivastine may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Acrivastine may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Acrivastine may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Acrivastine may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Acrivastine may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Acrivastine may decrease the excretion rate of Solriamfetol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Pyrithione may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Acrivastine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Acrivastine may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Acrivastine may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "Codeine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "Meperidine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Fentanyl may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Acrivastine may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Acrivastine may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Bepotastine may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Isotretinoin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Permethrin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Difluocortolone may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Acrivastine may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Acrivastine may decrease the excretion rate of Procainamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Pentostatin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Acrivastine may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Acrivastine may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Acrivastine may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Acrivastine may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Acrivastine may decrease the excretion rate of Cisplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Acrivastine may decrease the excretion rate of Carbamazepine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Acrivastine may decrease the excretion rate of Pemetrexed which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Acrivastine may decrease the excretion rate of Warfarin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Acrivastine may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Acrivastine may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Efonidipine may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Acrivastine may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Indapamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Canagliflozin may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Mersalyl may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Methyclothiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Bendroflumethiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Benzthiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Eplerenone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Hydroflumethiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Chlorothiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Trichlormethiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Polythiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Quinethazone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Theobromine may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "Tolvaptan may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Dapagliflozin may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "Indisulam may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Ertugliflozin may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Cyclopenthiazide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Epitizide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Potassium cation may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The therapeutic efficacy of Norepinephrine can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The therapeutic efficacy of Epinephrine can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The therapeutic efficacy of Droxidopa can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The therapeutic efficacy of Levonordefrin can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The therapeutic efficacy of Protokylol can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The therapeutic efficacy of Racepinephrine can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The therapeutic efficacy of Theodrenaline can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The therapeutic efficacy of Ephedrine can be increased when used in combination with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Acrivastine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}